US Stock MarketDetailed Quotes

VERU Veru Inc

Watchlist

0.487
-0.013-2.64%

Trading Mar 11 09:55 ET

71.26MMarket Cap-1.87P/E (TTM)

Veru Inc Stock Forum

Teddy123

Mar 5 07:31

Until Aug 25 to regain compliance

$Veru Inc (VERU.US)$
On February 27, 2025, the Company received a notification (the “Extension Notice”) from Nasdaq informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until August 25, 2025, to regain compliance with the minimum closing bid price requirement under the Rule for continued listing on Nasdaq. The Extension Notice has no immediate effect on the listing of the Company’s common stock. In connection with its reque...

Teddy123

Feb 21 08:10

Insider Purchase: Director at $VERU Buys 95,279 Shares

74419472

Feb 13 15:10

$Veru Inc (VERU.US)$ Why's this tanking?

JaYyYyYyY

Feb 13 09:40

$Veru Inc (VERU.US)$ why didnt rise~

This_Guy

Feb 13 05:43

$Veru Inc (VERU.US)$
taking a position here earning this morning

Trytosaveabit

Feb 13 05:38

Update! Other good stuff in report!

$Veru Inc (VERU.US)$ Veru (NASDAQ:VERU) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year.

Teddy123

Feb 13 05:32

Clinical research Analysis

$Veru Inc (VERU.US)$
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...